fr   en
Clinical Studies
Phase :    
Announcement :   
Select a Pharma :
Select a product :
Select a disease :
Choose date:
[<<]      «      1   |   2   |   3   |   4   |   5   |   6   |   7   |   8   |   9   |   10   |   11      »      [57]
Date Phase Anouncement Biotech Pharma Product Disease Country Other
2010-04-23 II Launch Affiris (Austria)   vaccine candidate AD02 Alzheimer disease Austria, Germany, France, the Czech Republic, Slovakia and Croatia See details
2010-04-21 II Result MolMed (Italy)   NGR-hTNF (vascular targeting agent) malignant pleural mesothelioma   See details
2010-04-21 II Result Swedish Orphan Biovitrum (Sweden)   enzyme replacement therapy to improve growth and development in preterm enzyme replacement therapy to improve growth and development in preterm infants receiving pasteurized breast milk and/or formula   See details
2010-04-20 Other Result ThromboGenics (Belgium)   microplasmin non surgical treatment of back of the eye disease   See details
2010-04-19 I-IIa Launch Ark Therapeutics (UK)   EG016 - (AD-VEGF D/adenoviral short-form Vascular Endothelial Growth Factor D gene construct) peripheral vascular disease Finland See details
2010-04-15 Other Result Active Biotech (Sweden) Teva Pharmaceutical (Israel) laquinimod relapsing remitting multiple sclerosis (RRMS)   See details
2010-04-15 IIa Result Kenta Biotech (Switzerland)   panobacumab (KBPA101 - fully human IgM monoclonal antibody) hospital-acquired pneumonia and ventilator-acquired pneumonia caused by P. aeruginosa   See details
2010-04-15 III Result   Sanofi-aventis lixisenatide (AVE 0010 - once-daily GLP-1 agonist) type 2 diabetes   See details
2010-04-14 II Launch Crucell (The Netherlands) Aeras Global TB Vaccine Foundation   Ad35-AERAS-402 (AdVac®-based tuberculosis vaccine) tuberculosis South Africa See details
2010-04-13 III Launch MolMed (Italy)   NGR-hTNF (vascular targeting agent) malignant pleural mesothelioma   See details
2010-04-13 III Result   Novartis (Switzerland) Gilenia® (FTY720 - fingolimod) multiple sclerosis   See details
2010-04-12 I Result Nabriva Therapeutics (Austria)   BC-3781 (pleuromutilin antibiotic) skin and skin structure infections, community-acquired pneumonia   See details
2010-04-12 I-IIa Launch SuppreMol (Germany)   SM101 (recombinant soluble non-glycosylated version of the Fc-receptor FcyRIIb) idiopathic thrombocytopenic purpura Germany, Belgium, Poland, and Russia See details
2010-04-07 I-II Launch Neovacs (France)   IFN alpha-Kinoid® (IFN-K) lupus France, Belgium an other European countries See details
2010-03-30 I-II Launch Prosensa (The Netherlands)   PRO044 Duchenne Muscular Dystrophy Belgium, Italy, Sweden See details
[<<]      «      1   |   2   |   3   |   4   |   5   |   6   |   7   |   8   |   9   |   10   |   11      »      [57]